198 related articles for article (PubMed ID: 29134746)
1. Fenofibrate induced PPAR alpha expression was attenuated by oestrogen receptor alpha overexpression in Hep3B cells.
Jeng LB; Velmurugan BK; Hsu HH; Wen SY; Shen CY; Lin CH; Lin YM; Chen RJ; Kuo WW; Huang CY
Environ Toxicol; 2018 Feb; 33(2):234-247. PubMed ID: 29134746
[TBL] [Abstract][Full Text] [Related]
2. E
Chang-Lee SN; Hsu HH; Shibu MA; Ho TJ; Tsai CH; Chen MC; Tu CC; Viswanadha VP; Kuo WW; Huang CY
Pathol Oncol Res; 2017 Jul; 23(3):477-485. PubMed ID: 27757837
[TBL] [Abstract][Full Text] [Related]
3. Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms.
Yamasaki D; Kawabe N; Nakamura H; Tachibana K; Ishimoto K; Tanaka T; Aburatani H; Sakai J; Hamakubo T; Kodama T; Doi T
Eur J Cell Biol; 2011 Aug; 90(8):657-64. PubMed ID: 21514001
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor α (ESR1) over-expression mediated apoptosis in Hep3B cells by binding with SP1 proteins.
Tu CC; Kumar VB; Day CH; Kuo WW; Yeh SP; Chen RJ; Liao CR; Chen HY; Tsai FJ; Wu WJ; Huang CY
J Mol Endocrinol; 2013; 51(1):203-12. PubMed ID: 23733894
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of estrogen receptor α (ERα) transcriptional activity by p27 is mediated by inhibition of ERα nuclear localization and modulation of the ERα transcriptional complex.
Jeon MJ; Yang W; Seo HS; Wang ES; Shin I
Cell Signal; 2012 Dec; 24(12):2249-58. PubMed ID: 22820506
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor α (PPARα) contributes to control of melanogenesis in B16 F10 melanoma cells.
Grabacka M; Wieczorek J; Michalczyk-Wetula D; Malinowski M; Wolan N; Wojcik K; Plonka PM
Arch Dermatol Res; 2017 Apr; 309(3):141-157. PubMed ID: 28084540
[TBL] [Abstract][Full Text] [Related]
7. Activation of PPAR alpha by fenofibrate inhibits apoptosis in vascular adventitial fibroblasts partly through SIRT1-mediated deacetylation of FoxO1.
Wang WR; Liu EQ; Zhang JY; Li YX; Yang XF; He YH; Zhang W; Jing T; Lin R
Exp Cell Res; 2015 Oct; 338(1):54-63. PubMed ID: 26226216
[TBL] [Abstract][Full Text] [Related]
8. Cyclin dependent kinase inhibitor p27(kip1) expression and subcellular localization in relation to cell proliferation in hepatocellualr carcinoma.
Shehata MA; Nosseir HR; Nagy HM; Farouk G
Egypt J Immunol; 2006; 13(1):115-30. PubMed ID: 17974156
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway.
Zhang N; Chu ES; Zhang J; Li X; Liang Q; Chen J; Chen M; Teoh N; Farrell G; Sung JJ; Yu J
Oncotarget; 2014 Sep; 5(18):8330-40. PubMed ID: 25327562
[TBL] [Abstract][Full Text] [Related]
10. The peroxisome proliferator-activated receptor alpha activator fenofibrate inhibits endothelin-1-induced cardiac fibroblast proliferation.
Ogata T; Miyauchi T; Irukayama-Tomobe Y; Takanashi M; Goto K; Yamaguchi I
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S279-82. PubMed ID: 15838301
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis.
Tanaka N; Moriya K; Kiyosawa K; Koike K; Aoyama T
Int J Cancer; 2008 Jan; 122(1):124-31. PubMed ID: 17764115
[TBL] [Abstract][Full Text] [Related]
12. Fenofibrate, a PPARα agonist, protect proximal tubular cells from albumin-bound fatty acids induced apoptosis via the activation of NF-kB.
Zuo N; Zheng X; Liu H; Ma X
Int J Clin Exp Pathol; 2015; 8(9):10653-61. PubMed ID: 26617775
[TBL] [Abstract][Full Text] [Related]
13. PPARα-dependent exacerbation of experimental colitis by the hypolipidemic drug fenofibrate.
Qi Y; Jiang C; Tanaka N; Krausz KW; Brocker CN; Fang ZZ; Bredell BX; Shah YM; Gonzalez FJ
Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(5):G564-73. PubMed ID: 25035112
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation.
Kamarajugadda S; Becker JR; Hanse EA; Mashek DG; Mashek MT; Hendrickson AM; Mullany LK; Albrecht JH
Oncotarget; 2016 Jul; 7(30):47674-47686. PubMed ID: 27351284
[TBL] [Abstract][Full Text] [Related]
15. [Interaction among peroxisome proliferators-activated receptor alpha, cytochrome P450 oxysterol 7α-hydroxylase and estrogen receptor and its association with intrahepatic cholestasis in pregnant rats].
Shi QY; Lin YG; Zhou X; Lin YQ; Yan S
Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):440-4. PubMed ID: 21029595
[TBL] [Abstract][Full Text] [Related]
16. Silibinin efficacy against human hepatocellular carcinoma.
Varghese L; Agarwal C; Tyagi A; Singh RP; Agarwal R
Clin Cancer Res; 2005 Dec; 11(23):8441-8. PubMed ID: 16322307
[TBL] [Abstract][Full Text] [Related]
17. Differential effects on lung cancer cell proliferation by agonists of glucocorticoid and PPARα receptors.
Liang H; Kowalczyk P; Junco JJ; Klug-De Santiago HL; Malik G; Wei SJ; Slaga TJ
Mol Carcinog; 2014 Sep; 53(9):753-63. PubMed ID: 23625588
[TBL] [Abstract][Full Text] [Related]
18. A novel antioestrogen agent (3R,6R)-bassiatin inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression in 17β-oestradiol-treated MCF-7 cells.
Meng L; Feng B; Tao H; Yang T; Meng Y; Zhu W; Huang C
Cell Biol Int; 2011 Jun; 35(6):599-605. PubMed ID: 21241249
[TBL] [Abstract][Full Text] [Related]
19. NF-κB increased expression of 17β-hydroxysteroid dehydrogenase 4 promotes HepG2 proliferation via inactivating estradiol.
Lu X; Ma P; Shi Y; Yao M; Hou L; Zhang P; Jiang L
Mol Cell Endocrinol; 2015 Feb; 401():1-11. PubMed ID: 25448063
[TBL] [Abstract][Full Text] [Related]
20. The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARα-tr, autonomously regulates proliferative and pro-inflammatory genes.
Thomas M; Bayha C; Klein K; Müller S; Weiss TS; Schwab M; Zanger UM
BMC Cancer; 2015 Jun; 15():488. PubMed ID: 26122096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
